Projects
ACTIVE — WORLD FIRST
Sitoiganap Patient Access Program — Kosovo
Pharmabel, in partnership with ERC, coordinates the access to Sitoiganap for international Glioblastoma patients in Kosovo — the first country in the world to grant full authorization and public reimbursement for this immunotherapy.
The program includes a complete care pathway: medical consultations at the Royal Hospital of Pristina, 5-star accommodation, transport, interpreter services, and 24/7 medical support.
Status: Active — accepting international referrals
Contact: [email protected]
UNDER CONSTRUCTION
Manufacturing Facility — Istog, Kosovo
Pharmabel’s first industrial site is currently under construction in Istog, Kosovo.
Fully owned and operated by Pharmabel, designed with maximum automation and robotics, built to strict GMP / EU standards.
Phase 1 (2025-2026)
Nutraceuticals
Phase 2
Non-antibiotic solid forms, through technology transfers
This facility is more than a production site, it is a model of what pharmaceutical manufacturing should look like: innovative, secure, and built to last.